Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gasser

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Neuroscience Applied|August 13, 2025
Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use programMatthias E Liechti, Peter Gasser, Helena D Aicher, et al.
The Journal of Nervous and Mental Disease|March 6, 2014
Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseasesPeter Gasser, Dominique Holstein, Yvonne Michel, et al.
Journal of Psychopharmacology (Oxford, England)|April 1, 2025
The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsTomislav Majić, Timo Torsten Schmidt, Anna Gröticke, et al.
Addictive Behaviors|December 29, 2004
Test-retest reliability of a lifetime drug use questionnaireChristoph Czermak, Michael Lehofer, Peter Gasser-Steiner, et al.
Biological Psychiatry|January 11, 2015
Acute Effects of Lysergic Acid Diethylamide in Healthy SubjectsYasmin Schmid, Florian Enzler, Peter Gasser, et al.
Frontiers in Psychiatry|March 1, 2021
Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical ResearchSara J Tai, Elizabeth M Nielson, Molly Lennard-Jones, et al.
Journal of Psychopharmacology (Oxford, England)|June 10, 2025
A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapyTorsten Passie, Anja Loizaga-Velder, Alicia Danforth, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Neuroscience Applied|August 13, 2025
Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use programMatthias E Liechti, Peter Gasser, Helena D Aicher, et al.
The Journal of Nervous and Mental Disease|March 6, 2014
Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseasesPeter Gasser, Dominique Holstein, Yvonne Michel, et al.
Journal of Psychopharmacology (Oxford, England)|April 1, 2025
The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsTomislav Majić, Timo Torsten Schmidt, Anna Gröticke, et al.
Addictive Behaviors|December 29, 2004
Test-retest reliability of a lifetime drug use questionnaireChristoph Czermak, Michael Lehofer, Peter Gasser-Steiner, et al.
Biological Psychiatry|January 11, 2015
Acute Effects of Lysergic Acid Diethylamide in Healthy SubjectsYasmin Schmid, Florian Enzler, Peter Gasser, et al.
Frontiers in Psychiatry|March 1, 2021
Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical ResearchSara J Tai, Elizabeth M Nielson, Molly Lennard-Jones, et al.
Journal of Psychopharmacology (Oxford, England)|June 10, 2025
A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapyTorsten Passie, Anja Loizaga-Velder, Alicia Danforth, et al.
Pageof 2